Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00093561 · ClinicalTrials.gov registry record · Phase 1
Lycopene in Preventing Prostate Cancer in Healthy Participants
A Phase 1 study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00093561 is a Phase 1 study that has completed, run by University of Illinois at Chicago.
The verdict
NCT00093561, a Phase 1 study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development or recurrence of cancer. The dietary supplement lycopene may prevent the development of prostate cancer. PURPOSE: This phase I trial is studying the side effects and best dose of lycopene in preventing prostate cancer in healthy participants.
Interventions
- DIETARY_SUPPLEMENT lycopene
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-08 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00093561
The ClinicalTrials.gov registry entry for NCT00093561 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lycopene is the first listed.
NCT00093561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00093561 about?
NCT00093561 is a clinical study titled "Lycopene in Preventing Prostate Cancer in Healthy Participants". RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development or recurrence of cancer. The dietary supplement lycopene may prevent the development of prostate cancer. PURPOSE: This phase I trial is studying the side effects and best dose of lycopene in preven...
What is the current status of trial NCT00093561?
This trial is currently completed. It is a Phase 1 study. The study started on 2004-08. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00093561?
The interventions under investigation include: lycopene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00093561?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.